Literature DB >> 2645876

Radiologic assessment as an outcome measure in rheumatoid arthritis.

J T Sharp1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2645876     DOI： 10.1002/anr.1780320218

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  22 in total

1.  Examining radiographic outcomes over time.

Authors:  Grace S Park; Weng Kee Wong; Dinesh Khanna; Richard H Gold; Harold E Paulus
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

2.  Severity of rheumatoid arthritis: the SEVERA study.

Authors:  Rafic Baddoura; Souha Haddad; Hassane Awada; Abdel Fattah Al-Masri; Georges Merheb; Said Attoui; Jad Okais; Jamil Messayke; Fadi Ghandour
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

3.  Cigarette smoking and rheumatoid arthritis severity.

Authors:  K G Saag; J R Cerhan; S Kolluri; K Ohashi; G W Hunninghake; D A Schwartz
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

4.  A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study.

Authors:  P Brennan; B Harrison; E Barrett; K Chakravarty; D Scott; A Silman; D Symmons
Journal:  BMJ       Date:  1996-08-24

5.  Prediction of radiographic damage in hands and feet in rheumatoid arthritis by clinical evaluation.

Authors:  M J Plant; J Saklatvala; P W Jones; P T Dawes
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

6.  Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components.

Authors:  M Dougados; B Combe; A Cantagrel; P Goupille; P Olive; M Schattenkirchner; S Meusser; L Paimela; R Rau; H Zeidler; M Leirisalo-Repo; K Peldan
Journal:  Ann Rheum Dis       Date:  1999-04       Impact factor: 19.103

7.  Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis.

Authors:  Haoling H Weng; Veena K Ranganath; Dinesh Khanna; Myungshin Oh; Daniel E Furst; Grace S Park; David A Elashoff; John T Sharp; Richard H Gold; James B Peter; Harold E Paulus
Journal:  J Rheumatol       Date:  2010-01-28       Impact factor: 4.666

8.  Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

Authors:  D M van der Heijde; M A van't Hof; P L van Riel; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

9.  Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin.

Authors:  P E Prete; J Zane; M Krailo; M Bulanowski
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

10.  MRI of knee arthritis in rheumatoid arthritis and spondylarthropathies.

Authors:  A Mundinger; M Ioannidou; S Meske; E Dinkel; A Beck; G Sigmund
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.